These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 23047512)

  • 1. Loss of E-cadherin in multidrug resistant breast cancer cell line MCF-7/Adr: possible implication in the enhanced invasive ability.
    Lu L; Zhou D; Jiang X; Song K; Li K; Ding W
    Eur Rev Med Pharmacol Sci; 2012 Sep; 16(9):1271-9. PubMed ID: 23047512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanisms of loss of beta 2-microglobulin expression in drug-resistant breast cancer sublines and its involvement in drug resistance.
    Ogretmen B; McCauley MD; Safa AR
    Biochemistry; 1998 Aug; 37(33):11679-91. PubMed ID: 9709006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial targeting topotecan-loaded liposomes for treating drug-resistant breast cancer and inhibiting invasive metastases of melanoma.
    Yu Y; Wang ZH; Zhang L; Yao HJ; Zhang Y; Li RJ; Ju RJ; Wang XX; Zhou J; Li N; Lu WL
    Biomaterials; 2012 Feb; 33(6):1808-20. PubMed ID: 22136714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anxa2 plays a critical role in enhanced invasiveness of the multidrug resistant human breast cancer cells.
    Zhang F; Zhang L; Zhang B; Wei X; Yang Y; Qi RZ; Ying G; Zhang N; Niu R
    J Proteome Res; 2009 Nov; 8(11):5041-7. PubMed ID: 19764771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of epithelial markers and acquisition of vimentin expression in adriamycin- and vinblastine-resistant human breast cancer cell lines.
    Sommers CL; Heckford SE; Skerker JM; Worland P; Torri JA; Thompson EW; Byers SW; Gelmann EP
    Cancer Res; 1992 Oct; 52(19):5190-7. PubMed ID: 1382837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of melatonin on invasive and metastatic properties of MCF-7 human breast cancer cells.
    Cos S; Fernández R; Güézmes A; Sánchez-Barceló EJ
    Cancer Res; 1998 Oct; 58(19):4383-90. PubMed ID: 9766668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Invasive properties of multidrug resistant human melanoma cells.
    Molinari A; Stringaro A; Gentile M; Colone M; Toccacieli L; Arancia G
    Ital J Anat Embryol; 2005; 110(2 Suppl 1):135-41. PubMed ID: 16101031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in beta-catenin phosphorylation and plakoglobin expression in human breast cancer cells.
    Sommers CL; Gelmann EP; Kemler R; Cowin P; Byers SW
    Cancer Res; 1994 Jul; 54(13):3544-52. PubMed ID: 8012979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complete reversal by thaliblastine of 490-fold adriamycin resistance in multidrug-resistant (MDR) human breast cancer cells. Evidence that multiple biochemical changes in MDR cells need not correspond to multiple functional determinants for drug resistance.
    Chen G; Waxman DJ
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1271-7. PubMed ID: 7562498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Negative regulation of MDR1 promoter activity in MCF-7, but not in multidrug resistant MCF-7/Adr, cells by cross-coupled NF-kappa B/p65 and c-Fos transcription factors and their interaction with the CAAT region.
    Ogretmen B; Safa AR
    Biochemistry; 1999 Feb; 38(7):2189-99. PubMed ID: 10026303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Up-regulation of c-myc expression in MCF-7/Adr human breast cancer cells and its association with resistance against doxorubicin].
    Chen J; Yuan YW; Zhang JR; Zhou DY
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Feb; 22(2):124-6. PubMed ID: 12390804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P-glycoprotein associates with Anxa2 and promotes invasion in multidrug resistant breast cancer cells.
    Zhang F; Zhang H; Wang Z; Yu M; Tian R; Ji W; Yang Y; Niu R
    Biochem Pharmacol; 2014 Jan; 87(2):292-302. PubMed ID: 24239898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinctive alterations of invasiveness, drug resistance and cell-cell organization in 3D-cultures of MCF-7, a human breast cancer cell line, and its multidrug resistant variant.
    dit Faute MA; Laurent L; Ploton D; Poupon MF; Jardillier JC; Bobichon H
    Clin Exp Metastasis; 2002; 19(2):161-8. PubMed ID: 11964080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell adhesion molecule uvomorulin expression in human breast cancer cell lines: relationship to morphology and invasive capacities.
    Sommers CL; Thompson EW; Torri JA; Kemler R; Gelmann EP; Byers SW
    Cell Growth Differ; 1991 Aug; 2(8):365-72. PubMed ID: 1793731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the mutated p53 tumor suppressor protein and its molecular and biochemical characterization in multidrug resistant MCF-7/Adr human breast cancer cells.
    Ogretmen B; Safa AR
    Oncogene; 1997 Jan; 14(4):499-506. PubMed ID: 9053847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Status of estrogen receptor affects the drug sensitivity of drug-resistant MCF-7/Adr human breast cancer cells to droloxifene and Adriamycin].
    Gao HD; Sun JZ; Bi DS; Ma R
    Ai Zheng; 2003 Apr; 22(4):376-9. PubMed ID: 12703992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered expression of integrins in adriamycin-resistant human breast cancer cells.
    Narita T; Kimura N; Sato M; Matsuura N; Kannagi R
    Anticancer Res; 1998; 18(1A):257-62. PubMed ID: 9568087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318.
    Chen LM; Liang YJ; Ruan JW; Ding Y; Wang XW; Shi Z; Gu LQ; Yang XP; Fu LW
    J Pharm Pharmacol; 2004 Aug; 56(8):1061-6. PubMed ID: 15285852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of microRNA in drug-resistant breast cancer cell line MCF-7/ADR].
    Cui XY; Guo YJ; Yao HR
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Oct; 28(10):1813-5. PubMed ID: 18971180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of E-cadherin and β-catenin in two cholangiocarcinoma cell lines (OZ and HuCCT1) with different degree of invasiveness of the primary tumor.
    Abuetabh Y; Persad S; Nagamori S; Huggins J; Al-Bahrani R; Sergi C
    Ann Clin Lab Sci; 2011; 41(3):217-23. PubMed ID: 22075503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.